US EditionTrump administration asks court to pause Louisiana lawsuit targeting abortion pill access while it conducts review
DOJ requests court pause on Louisiana's suit to wait for FDA's safety review of mifepristone, used in over two-thirds of U.S. abortions, to avoid duplicative rulings.
- On Tuesday, the U.S. Department of Justice filed a motion asking a judge to pause Louisiana's lawsuit challenging FDA decisions while the agency reevaluates mifepristone's safety.
- Louisiana's suit, filed last October, seeks to reinstate an in-person-only rule banning telemedicine prescriptions and mail delivery of mifepristone, echoing the Justice Department's stance last year.
- Recent data show that as of last year, more than a quarter of U.S. abortions used telemedicine, while Americans United for Life alleged no public evidence of an active FDA review exists.
- A hearing is scheduled for Feb. 24, and DOJ warned that allowing Louisiana's challenge could set precedent for progressive states to seek looser pill regulations.
- Anti-Abortion groups warn the filing deepens frustration with the Trump administration for not curbing mifepristone, used in more than two-thirds of U.S. abortions, risking wide national impact.
23 Articles
23 Articles
Trump tries to pause abortion pill lawsuit over Louisiana attorney general’s objections
The Justice Department is asking a federal court to pause Louisiana’s lawsuit that challenges the deregulation of abortion pills, noting that the FDA is already conducting a review. President Donald Trump’s Department of Justice (DOJ) [...]
Trump DOJ seeks stay for Louisiana suit to end mailing of abortion drugs
Photo illustration by Natalie Behring/Getty ImagesThe Trump administration has asked a federal judge in Louisiana to pause before ruling on the state’s lawsuit seeking to end the Food and Drug Administration policy that allows doctors to prescribe abortion medication without an in-person visit. The U.S. Department of Justice filed for a stay Tuesday in the lawsuit state Attorney General Liz Murrill filed against the Food and Drug Administration …
Trump administration asks federal court to pause Louisiana’s abortion pill challenge
WASHINGTON (OSV News) — A key national pro-life group has accused the U.S. Department of Justice of undermining Louisiana’s efforts to roll back the Biden administration‘s eased restrictions on mifepristone when it asked a court to pause the Pelican State’s challenge to that abortion policy. In October, Louisiana Attorney General Liz Murrill, alongside Rosalie Markezich, who said she was coerced into taking abortifacient drugs by her then-boyfri…
DOJ asks judge to delay abortion pill restrictions as FDA review could stretch into 2027
The Department of Justice (DOJ) on Jan. 27 asked a federal judge to delay or dismiss a Louisiana lawsuit seeking to restore in-person safeguards for abortion… The post DOJ asks judge to delay abortion pill restrictions as FDA review could stretch into 2027 appeared first on CatholicVote org.
FDA Requests Pause of Abortion Pill Lawsuit
The Food and Drug Administration (FDA) asked a federal court on Jan. 27 to pause a lawsuit that Louisiana brought to reverse the Biden administration’s deregulation of the abortion pill mifepristone. The agency asked a federal court to “stay all proceedings in the matter” while it studies its policy permitting mifepristone to be mailed to patients without an in-person visit to a doctor. In an accompanying brief, the FDA said that the process “of…
Food and Drug Administration Requests Pause of Abortion Pill Lawsuit - The Thinking Conservative News
FDA asked a federal court to pause a lawsuit Louisiana brought to reverse the Biden administration’s deregulation of the abortion pill mifepristone. The post Food and Drug Administration Requests Pause of Abortion Pill Lawsuit appeared first on The Thinking Conservative News.
Coverage Details
Bias Distribution
- 40% of the sources are Center, 40% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
